CAR-20/19-T cells
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CAR-20/19-T cells, covering 2021-05-07 to 2026-02-23. Get the full timeline:
Most recent: Clinical Trial Update: CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies [Phase 1, Phase 2]